HanchorBio Inc. (TPE:7827)
Taiwan · Delayed Price · Currency is TWD 169.50
+4.50 (2.73%)
At close: Jul 16, 2026
HanchorBio Market Cap
HanchorBio has a market cap or net worth of 22.07 billion as of July 16, 2026. Its market cap has increased by 191.00% in one year.
Market Cap
22.07B
Enterprise Value
21.51B
Revenue
312.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
169.50
ChartMarket Cap Chart
Since June 20, 2025, HanchorBio's market cap has increased from 5.52B to 22.07B, an increase of 299.81%. That is a compound annual growth rate of 264.62%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 22.07B | 91.70% |
| Dec 31, 2025 | 11.51B | 108.56% |
| Jun 20, 2025 | 5.52B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TLC BioSciences | 32.79B |
| Elixiron Immunotherapeutics (Cayman) Limited | 10.82B |
| Uwell Biopharma | 7.63B |
| Intelligene | 6.84B |
| Tripartite Therapeutics | 6.24B |
| Obigen Pharma | 3.90B |
| Pet Pharm Biotech | 2.87B |
| BIONET Therapeutics | 2.17B |